McClure Matthew W. has filed 9 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 72000 shares of Aligos Therapeutics, Inc. ($ALGS) on March 01, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2024 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 72000 | $0.00 | 72,000.0000 | 3,003,855 | 9999.99% | 2.40% |
| Feb. 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | D | Stock Option (Right to Buy) | 255626 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 8.51% |
| Feb. 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | D | Stock Option (Right to Buy) | 92000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 3.06% |
| Feb. 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | D | Stock Option (Right to Buy) | 23000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.77% |
| Feb. 28, 2024 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 75183 | $0.00 | 75,183.0000 | 3,003,855 | 9999.99% | 2.50% |
| Feb. 28, 2024 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 65713 | $0.00 | 65,713.0000 | 3,003,855 | 9999.99% | 2.19% |
| Feb. 28, 2024 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 16428 | $0.00 | 16,428.0000 | 3,003,855 | 9999.99% | 0.55% |
| Sept. 8, 2023 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2023 | Aligos Therapeutics, Inc. | $ALGS | McClure Matthew W. | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |